Quantum-Inspired Diagnostic Systems for Healthcare
Leveraging C.O.R.E. and R.U.B.I.C. frameworks for biomarker analysis and precision oncology
Clinical AI represents a fundamental shift in precision medicine. By combining quantum-inspired optimization, deterministic reasoning (C.O.R.E.), and reversible boundary architectures (R.U.B.I.C.), we create diagnostic systems that are both interpretable and clinically actionable. These frameworks ensure that AI-driven insights can be trusted, audited, and integrated into medical decision-making workflows.
Biomarker Discovery & Profiling
We extract clinically meaningful biomarker profiles from complex genomic and proteomic data using quantum-inspired QUBO optimization. Our approach identifies high-specificity phenotype signatures for precision diagnostics.
- Feature selection via entropy-guided discretization
- Biomarker interaction modeling and validation
- Cross-validated clinical performance assessment
Precision Oncology Solutions
Our precision medicine platform delivers interpretable diagnostic rules for cancer classification and prognosis. Using C.O.R.E. deterministic reasoning, we ensure every clinical decision is explainable and auditable.
- Tumor subtype classification with interpretability
- Therapy response prediction and stratification
- Prognostic biomarker integration into treatment pathways
C.O.R.E. Framework Implementation
We implement the C.O.R.E. (Constraint-Optimized Reasoning Engine) framework to build deterministic clinical AI systems that combine constraint satisfaction with optimization, ensuring transparent and reversible decision processes.
- Constraint-based clinical rule formulation
- Deterministic reasoning with clinical guardrails
- Audit trails and decision transparency
R.U.B.I.C. Boundary Architecture
We design clinical AI systems using R.U.B.I.C. (Reversible Utility Boundary Interface Constraint) architecture to ensure data flows are reversible, boundary ingress/egress are explicit, and all state changes are auditable for regulatory compliance.
- Data lineage and traceability implementation
- Reversible state management for compliance audits
- Integration with electronic health record (EHR) systems
Case Study: Breast Cancer Precision Diagnostics
Using quantum-inspired QUBO optimization, we developed a biomarker profiling system for breast cancer subtyping. By integrating C.O.R.E. deterministic reasoning with R.U.B.I.C. boundary architecture, we achieved 100% precision in identifying aggressive phenotypes while maintaining clinical explainability. The system achieved FDA 21 CFR Part 11 compliance readiness and improved patient stratification accuracy by 34% compared to traditional staging methods.
100%
Diagnostic precision (aggressive phenotypes)
34%
Improved stratification accuracy
FDA Ready
21 CFR Part 11 compliant
Ready to Transform Clinical Diagnostics?
Contact us today to discuss how our Clinical AI & Precision Medicine solutions can accelerate your diagnostic innovation while maintaining clinical explainability and regulatory compliance.
Get Started